Резултати

еНаука >  Резултати >  Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
Назив: Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
Аутори De Backer, G.; Jankowski, P.; Dilić, M.; Lalić, N.; Lović, D.  ; Miličić, D.; Vulić, D.; Begić, A.; Durak Nalbantić, A.; Hadzibegić, N.;
Година: 2019
Публикација: Atherosclerosis
ISSN: 0021-9150 Atherosclerosis Претражи идентификатор
Издавач: Elsevier Ireland Ltd
Тип резултата: Научни чланак
Колација: vol. 285 str. 135-146
DOI: 10.1016/j.atherosclerosis.2019.03.014
WoS-ID: 000468732700018
Scopus-ID: 2-s2.0-85064931797
PMID: 31054483
URI: https://enauka.gov.rs/handle/123456789/572529
https://imagine.imgge.bg.ac.rs/handle/123456789/1231
Пројекат: The EUROASPIRE V survey was carried out under the auspices of the ESC –EORP. Since the start of EORP, the following companies have supported the programme: Amgen, Eli Lilly, Pfizer, Sanofi, Ferrer and Novo Nordisk. The sponsors of the EUROASPIRE surveys had no role in the design, data collection, data analysis, data interpretation, decision to publish, or writing the manuscript. The EUROASPIRE Study Group is grateful to the administrative staff, physicians, nurses, and other personnel in the hospitals in which the survey was carried out and to all patients who participated in the surveys.
М-категорија: 
21M21 - Рад у врхунском међ. часопису

226
SCOPUSTM
85
PubMed CentralTM
141
OpenCitations
204
WEB OF SCIENCETM
Алт метрика
Dimensions

Пронађи DOI

Unpaywall

Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.